MedPacto
Korea - SeoulBiotechnology
Focus: MedPacto is a Korea-based biotechnology company specializing in small molecule combination therapies. Limited public data restricts full market position assessment.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About MedPacto
AI assessmentNot HiringNo open roles listed right now. Follow MedPacto to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
11 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
TEW-7197
Healthy VolunteersClinical Trials (1)
NCT03704675Effect of Food on the Pharmacokinetics of TEW-7197 in Healthy Subjects
Phase 1Help build intelligence for MedPacto
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.